Key terms
About SNSE
Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SNSE news
Apr 24
2:21pm ET
Sensei Biotherapeutics management to meet with Oppenheimer
Apr 12
4:43pm ET
Sensei Biotherapeutics Extends Relationship with Former CFO
Apr 04
4:15pm ET
Sensei Biotherapeutics: Peer-reviewed research paper on SNS-101 published
Apr 02
8:02am ET
Sensei Biotherapeutics CFO Erin Colgan Resigns Amicably
Mar 25
9:20pm ET
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM) and Sensei Biotherapeutics (SNSE)
Feb 29
8:07am ET
Sensei Biotherapeutics (SNSE) Gets a Buy from Oppenheimer
Feb 29
6:50am ET
Analysts Offer Insights on Healthcare Companies: Sensei Biotherapeutics (SNSE), Abbott Labs (ABT) and Personalis (PSNL)
Feb 29
6:30am ET
Buy Rating Affirmed for Sensei Biotherapeutics on Strong Fiscal Health and Promising Clinical Trials
Feb 28
7:33am ET
Sensei Biotherapeutics reports FY23 EPS ($1.22), consensus ($1.22)
Feb 09
4:56am ET
Sensei Biotherapeutics Streamlines Board, Appoints Interim Chair
Feb 09
4:56am ET
Sensei Biotherapeutics Announces Board Member Resignation and Consultant Role
No recent press releases are available for SNSE
SNSE Financials
Key terms
Ad Feedback
SNSE Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SNSE Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
